Transgene Biotek Ltd.
Snapshot View

2.88 +0.03 ▲1.1%

27 January 2023, 01:55:00 PM
Volume: 6,005

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.transgenebiotek.com
Market Cap 21.82 Cr.
Enterprise Value(EV) 34.13 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -1.10 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 46.72 Trailing Twelve Months Ending 2022-09
Book Value / Share 1.88 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.53 Calculated using Price: 2.88
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 7.58 Cr. 75,770,000 Shares
FaceValue 10
Company Profile
Transgene Biotek Ltd (TBL) was set up in 1991, and was probably the first true Biotechnology Company in India. It is listed on the Indian Stock Exchanges and is involved in the development of several cutting edge technologies.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.05%
1 Week
+1.41%
1 Month
-1.71%
3 Month
-7.40%
6 Month
-15.54%
1 Year
-19.55%
2 Year
-25.19%
5 Year
+21.52%
10 Year
-21.74%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -50.54 -9.63 -11.78 -17.03 -11.57 -18.31 -28.73 -38.00 -52.52
Return on Capital Employed (%) -47.36 -8.84 -10.85 -14.68 -6.74 -14.83 -22.10 -26.55 -32.32
Return on Assets (%) -36.70 -5.45 -6.56 -7.77 -3.35 -4.84 -6.39 -6.45 -6.84

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 206 191 174 59 52 44 33 22 17 14
Non Curr. Liab. 127 127 127 127 120 120 120 120 121 121
Curr. Liab. 26 25 11 12 14 13 14 14 9 10
Minority Int.
Equity & Liab. 358 344 313 198 187 177 167 157 147 145
Non Curr. Assets 338 326 310 197 186 176 166 156 146 144
Curr. Assets 20 18 3 1 1 1 1 1 1 1
Misc. Exp. not W/O
Total Assets 358 344 313 198 187 177 167 157 147 145

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1 0 0 0 0 0 0 0 0
Other Income 1 0 0 1 7 2 0 0 0 0
Total Income 2 0 0 1 7 2 0 0 0 0
Total Expenditure -3 -2 -1 -3 -2 -1 -1 -1 -1 -1
PBIDT -1 -2 -1 -2 5 1 -1 0 0 -1
Interest 0 0 0 -1 0 0 0 0 0
Depreciation -17 -17 -21 -18 -10 -10 -10 -10 -10 -7
Taxation -1
Exceptional Items -115
PAT -133 -19 -22 -20 -6 -9 -11 -10 -10 -8
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -133 -19 -22 -20 -6 -9 -11 -10 -10 -8
Adjusted EPS -18 -3 -3 -3 -1 -1 -1 -1 -1 -1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 13 -2 4 6 0 -1 -2 0 0 0
Cash Fr. Inv. -15 1 -5 -6 3 2 0 0
Cash Fr. Finan. 2 1 1 -2 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 23.64 23.64 23.64 23.64 23.64 23.64 23.64 23.64 23.64
Public 76.36 76.36 76.36 76.36 76.36 76.36 76.36 76.36 76.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 27 Jan 2023
Board Meeting Intimation for Board Meeting.
TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve This is to inform you that a Meeting of the Board of Directors will be held on Tuesday 14th February 2023 at 11.00 am to transact the following business:1) To consider and approve the unaudited standalone & consolidated financial results for the quarter ended on 31st December 2022 along with the Limited Review Report as provided by the Statutory Auditor of the Company.
Thu, 12 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Confirmation Certificate Details in the matter of Regulation 74(5) of SEBI (Depositories & Participants) Regulations 2018.
Sat, 07 Jan 2023
Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (LODR) Regulations 2015.
Disclosure of Related Party Transactions under Regulation 23(9) of SEBI (LODR) Regulations 2015.

Technical Scans View Details >>

Wed, 25 Jan 2023
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
CCI Bullish CCI Bullish
Tue, 24 Jan 2023
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,040.60 +0.0%
Divi's Laboratories Ltd. 88,552.35 3,361.85 +0.8%
Cipla Ltd. 83,862.25 1,042.55 +0.7%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,304.80 +2.5%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,223.25 0.0%
Torrent Pharmaceuticals Ltd. 52,497.96 1,531.45 -1.6%
Abbott India Ltd. 45,101.64 21,203.10 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,040.60 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,361.85 +0.8%
Cipla Ltd. Consolidated 2022-09 32.68 1,042.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,304.80 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,223.25 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,531.45 -1.6%
Abbott India Ltd. Standalone 2022-09 51.15 21,203.10 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.60 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,361.85 +0.8%
Cipla Ltd. Consolidated 2022-09 3.83 1,042.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,304.80 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,223.25 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,531.45 -1.6%
Abbott India Ltd. Standalone 2022-09 16.62 21,203.10 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.60 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,361.85 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,042.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,304.80 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,223.25 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,531.45 -1.6%
Abbott India Ltd. Standalone 2022-03 0.00 21,203.10 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.60 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,361.85 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,042.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,304.80 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,223.25 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,531.45 -1.6%
Abbott India Ltd. Standalone 2022-03 29.95 21,203.10 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.60 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,361.85 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,042.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,304.80 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,223.25 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,531.45 -1.6%
Abbott India Ltd. Standalone 2022-03 29.95 21,203.10 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.60 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,361.85 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,042.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,304.80 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,223.25 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,531.45 -1.6%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,203.10 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.60 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,361.85 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,042.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,304.80 +2.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,223.25 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,531.45 -1.6%
Abbott India Ltd. Standalone 2022-03 798.70 21,203.10 -0.4%

FAQ's On Transgene Biotek Ltd.

What is Transgene Biotek share price?

Can I buy Transgene Biotek shares now?

What is the Market Cap of Transgene Biotek?

What are the key metrics to analyse Transgene Biotek?

What is the 52 Week High and Low of Transgene Biotek?

What is the trend of Transgene Biotek share price?